title: Mucosal metastases in malignant melanoma.
abstract: BACKGROUND
  We present the case of a patient with malignant melanoma stage IV according to the American Joint Committee on Cancer (AJCC) classification and an unusual pattern of metastasis to the mucosa of the esophagus, the stomach, the bladder and the palatine tonsil.
  
  
  METHODS
  A 38-year-old male patient with metastatic malignant melanoma of stage III (AJCC) was admitted for initiation of adjuvant therapy. 4 months earlier a primary melanoma of the left upper leg had been excised and 2 months later the patient had undergone a left inguinal lymph node dissection revealing 2 metastatic lymph nodes. On admission the patient complained of a sore throat and right cervical lymphadenopathy. He underwent a tonsillectomy and a lymphadenectomy which both revealed melanoma metastases. A PET scan using F-18-fluorodeoxyglucose (FDG) showed focal metabolic activity in the middle mediastinum. Two cycles of dacarbazine (DTIC) chemotherapy were performed during which the patient developed cutaneous metastases, dyspepsia, and mild hematemesis. Gastroscopy revealed bleeding from mucosal metastases of the esophagus and stomach. A few weeks later the patient developed macroscopic hematuria. A cystoscopy was performed and showed metastases to the mucosa of the bladder. Nutrient vessels of these bladder metastases were embolized in order to control bleeding. The patient is currently alive with progressive disease.
  
  
  RESULTS
  This case presents common and uncommon sites of metastatic melanoma to the mucosa with the typical clinical manifestations in a single patient.
authors.affiliation: Klinische Kooperationseinheit Dermatoonkologie des DKFZ an der Klinik für Dermatologie, Venerologie und Allergologie am Universitätsklinikum Mannheim, Germany. w.fink@dkfz-heidelberg.de
authors.forename: W
authors.initials: W
authors.lastname: Fink
authors.forename: A
authors.initials: A
authors.lastname: Zimpfer
authors.forename: S
authors.initials: S
authors.lastname: Ugurel
mesh_terms: D000328:Adult; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004938:Esophageal Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D005753:Gastric Mucosa / Q000473:pathology; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D009092:Mucous Membrane / Q000473:pathology; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy; D013274:Stomach Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D014055:Tomography, Emission-Computed; D014067:Tonsillar Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy